Fierce Healthcare

Optimizing Wound Management: Clinical Evidence, Real-World Data, and Cost Benefits of Collagenase SANTYL Ointment

Recent research is revealing key insights about the therapeutic potential of clostridial collagenase. Join us for this upcoming webinar to learn about new data on SANTYL® ointment’s unique mechanisms ...
WGN Radio

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of ...
Nasdaq

MediWound Ltd. Publishes Post Hoc Analysis Comparing EscharEx® and Collagenase Ointment in Wounds Journal

MediWound Ltd. announced the publication of a peer-reviewed post hoc analysis in the journal Wounds, based on data from its Phase II ChronEx clinical trial for patients with venous leg ulcers (VLUs).
Becker's Hospital Review

Advancing Real World Wound Care with Dr. Jaideep Banerjee of Smith+Nephew

This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized ...